Newyddion Ariannol

CityAM Business with personality

The Motley Fool UK The Motley Fool UK: Share Tips, Investing and Stock Market News

Proactiveinvestors United Kingdom articles Proactiveinvestors United Kingdom articles RSS feed

Morningstar Research and Commentary Morningstar: a leading provider of investment information worldwide.

  • The Value Investing Conundrum
    on Medi 18, 2020 at 10:54 am

    Editor's Views: Value investing makes sense, but how long can investors be expected to wait for the style to stage a turnaround? 

  • M&G Recovery Under Review
    on Medi 18, 2020 at 10:06 am

    Tom Dobell will step down from running the £1.4 billion M&G Recovery fund after a sustained period of underperformance. Morningstar […]

  • Kier's Results Delay Rattles Investors
    on Medi 18, 2020 at 9:12 am

    The Week: Morningstar columnist Rodney Hobson rails at Kier's bungled results announcement, which left shareholders in the dark for nearly […]

  • UK Property Funds Begin to Lift Suspensions
    on Medi 17, 2020 at 5:19 pm

    One of the largest open-ended funds in the sector, Threadneedle Property, is to open to investors next week after six months of being gated

  • Stock of the Week: All Posts
    on Medi 17, 2020 at 2:49 pm

    Every week we ask our Twitter followers which stocks we should write about - previous winners include Vodafone, Burberry, SoftBank and […]

  • Stock of the Week: Taiwan Semiconductor
    on Medi 17, 2020 at 11:43 am

    Taiwanese chip-maker has become the manufacturer of choice for the world's biggest tech hardware firms, and investors have chased the […]

  • 3 Rated ESG Funds
    on Medi 17, 2020 at 11:00 am

    VIDEO: Morningstar analyst Ronald van Genderen explains how he takes ESG factors into account and which rated funds score highly

  • Which Funds Launched in August?
    on Medi 17, 2020 at 9:48 am

    Five new funds launched last month. We look at these new offerings as well as more established alternatives 

The Adventurous Investor Investment trusts, ETFs, alternatives and more.....

  • The inflation debate – which stocks to buy in an inflation bubble plus new UK focused growth trust
    on Medi 17, 2020 at 10:48 am

    Worth picking up today on a note from SG’s Global quantitative research team from yesterday called “There is nothing to fear but fear itself – Hedging inflation risk with equities”. This is very timely because as readers of this blog... Continue reading →

  • Some left field thinking – UK population 100 million by 2050? Why not?
    on Medi 16, 2020 at 12:21 pm

    I’m been spending quite a bit of time recently contemplating why UK productivity growth has been slow in the recent decade and how we can boost economic growth over the next few decades. Marxists are ready at hand with their... Continue reading →

  • More on Russia, Millenial charts and a reminder on events
    on Medi 15, 2020 at 10:10 am

    Yesterday I observed that it is becoming increasingly hard to mount an enthusiastic defence of emerging market assets. The one exception in my view is Russia, about which I have become increasingly bullish. I’ll ignore my long list of worries... Continue reading →

  • Monday Macro – EM and the US election and the bullish case for UK assets
    on Medi 14, 2020 at 2:05 pm

    The wonderful Ian Leslie highlighted last week a great little paper by academic James Crabtree which I think is well worth reading. Its premise – “U.S. allies have grown comfortable with Trump and his tough approach to China—and are anxious... Continue reading →

  • Emerging markets: another patchy month in August plus new homeless homes fund looking to IPO
    on Medi 9, 2020 at 10:28 am

    Interesting numbers out last week from Daniel Salter, Head of Equity Strategy at Renaissance Capital. He’s been looking at returns for August for EM and frontier markets. Overall EM equities lagged, up just 2.1%, but excluding China +5.6%, EM ex-China... Continue reading →

  • Dates for your diary – two fab ETF events well worth attending
    on Medi 8, 2020 at 10:25 am

    I’m heavily involved in two up and coming events in the next few weeks which I think will appeal to any Adventurous Investors interested in all things ETF or factor investing related. The first, next week, is on Emerging Markets... Continue reading →

  • Monday Macro: Reading the tea leaves – whither inflation?
    on Medi 7, 2020 at 3:23 pm

    I keep babbling on about inflation, and expectations of its imminent return, because I think it is of huge importance. Two thoughts. The first is that we are mid-way through a multiyear liquidity bubble in which central banks have a... Continue reading →

  • Why cash is a drain on your wealth
    on Medi 3, 2020 at 1:16 pm

    From my Citywire column yesterday…. It will probably surprise most Citywire readers, but I do actually read many of the comments after my regular columns. Obviously, I welcome plaudits (!), but it’s the questions that I tend to find most... Continue reading →

Stock Market Wire UK Market News from Stock Market Wire

  • Fusion Antibodies makes positive progress on Covid-19 antigen development
    on Medi 18, 2020 at 1:08 pm

    Antibody supplier Fusion Antibodies said it had made positive progress on the design of SARS-CoV-2 proteins, commonly known as Coronavirus spike proteins. The antigens had been tested by external partners against patient blood samples and showed a 100% correlation with results from a leading certified benchmark test. 'The company's extensive antigen manufacturing capabilities means that Fusion has been able to express high-purity antigens on a commercially viable scale for the development of diagnostic tests,' Fusion said. 'The company is now offering these antigens on a commercial basis to companies and researchers worldwide.' Fusion said its antigens were able to confirm recent past infections and determine levels of neutralising antibodies to Covid-19. 'We are using these high quality antigens to pan our human antibody library for SARS-CoV-2 neutralising antibodies, and we are delighted to now be able to make these antigens available to companies and researchers around the world to test, track and trace this disease,' chief technology officer Richard Buick said. At 2:08pm: (LON:FAB) Fusion Antibodies Plc Ord 4p share price was +87.5p at 180p Story provided by

  • Games Workshop appoints Elaine O'Donnell as chairman
    on Medi 18, 2020 at 12:14 pm

    Miniature wargames manufacturer Games Workshop said it had appointed existing director Elaine O'Donnell as its new chairman, effective 1 January. O'Donnell had been an independent non-executive director of the company since 2013. She would take over from Nick Donaldson, whose pending retirement was announced in July. At 1:14pm: (LON:GAW) Games Workshop Group PLC share price was +220p at 10070p Story provided by

  • Emmerson narrows losses, makes progress on moving Khemisset towards 'shovel ready' status
    on Medi 18, 2020 at 8:48 am

    Potash development company Emmerson reported narrower losses in the first half of the year, and touted progress on moving Khemisset, located in Morrocom towards 'shovel ready' status. For the six-month period ended 30 June 2020, pre-tax losses narrowed to 4K, from 9K on-year. Emmerson hailed a number of significant developments, which it said had moved Khemisset closer towards 'shovel ready' status. The company said it was on track to secure the main permits for the project by H1 2021. At 9:48am: (LON:EML) Emmerson Plc share price was 0p at 4.2p Story provided by

  • Syncona portfolio company Autolus Therapeutics releases positive trial data
    on Medi 18, 2020 at 8:48 am

    Healthcare investor Syncona welcomed the release of new data by portfolio company Autolus Therapeutics highlighting progress on a cancer treatment. The data had been released during the European Society for Medical Oncology Virtual Congress 2020, beginning 18 September. A clinical trial had investigated Autolus's T-cell therapy in relapsed/refractory diffuse large B cell lymphoma. 'The data support a best in class profile with a high level of complete remissions and a well tolerated safety profile,' Autolus chairman and chief executive Christian Itin said. At 9:48am: (LON:SYNC) Syncona Limited share price was -0.75p at 234.25p Story provided by

  • Faron Pharmaceuticals' immunotherapy shows anti-tumour activity in clinical trial
    on Medi 18, 2020 at 8:41 am

    Biopharmaceutical company Faron Pharmaceuticals said a clinical trial of its potential immunotherapy for difficult-to-treat cancer had triggered anti-tumour activity in patients. The immunotherapy sought to target Clever-1 positive tumour associated macrophages, or TAM, in selected metastatic or inoperable solid tumours. The patients in the trial also increased circulating T cells or had a 'substantial increase in natural killer cells in the blood, all of which are considered as strong signs of this desired immune activation,' the company said in a presentation at ESMO Virtual Congress 2020. Full (transient) Clever-1 receptor occupancy was achieved and, despite its relatively fast clearance from circulation, sustained pharmacodynamic effects by bexmarilimab were observed,' it added. At 9:41am: (LON:FARN) Faron Pharmaceuticals share price was +17.5p at 442.5p Story provided by

  • Argos Resources first-half losses widened on oil prices weakness
    on Medi 18, 2020 at 8:31 am

    Oil and gas company Argos Resources reported wider losses in the first half of the year amid weaker oil prices. For the six months ended 30 June 2020, pre-tax losses widened to $192K from $176K on-year and cash reserves stood at $560K as at 30 June 2020, down from $768K. During the reporting period of the first half of the year, Brent crude oil prices plummeted from over $65/bbl at year-end 2019 to a low of $20/bbl in April 2020, before recovering somewhat to around $42/bbl by the end of June, the company said. 'The industry has been hit hard by this unexpected sharp drop in demand and commodity prices, and has responded by reducing costs, cutting capital expenditure and delaying projects,' it added. The company said it inended to request an extension to the current second phase of the licence that was due to expire in May 2021, citing more time needed to recover from the downturn. At 9:31am: (LON:ARG) Argos Resources Ltd share price was -0.05p at 1.85p Story provided by

  • Renalytix AI launches kidney disease diagnostic reporting platform
    on Medi 18, 2020 at 8:31 am

    Kidney disease diagnostics group Renalytix AI said it had commercially launched a clinical test reporting platform within the Mount Sinai Health System in New York City. The company said its KidneyIntelX risk assessment of kidney function was now commercially available for patients with early stage diabetic kidney disease. The launch also included the addition of a physician education and support program developed with leadership of the Mount Sinai Departments of Medicine and Population Health Science and Policy. Agreements with Laboratory Corporation of America and a national medical logistics provider were recently signed to support sample collection at five patient service centers servicing Mount Sinai patients. Renalytix AI said it intended to scale th process with laboratory service providers and logistics providers across multiple territories in the US to ensure patient blood samples could be securely delivered to its laboratories. At 9:31am: (LON:RENX) Renalytix Ai PLC share price was +20p at 535p Story provided by

  • Eurasia Mining appoints James Nieuwenhuys as CEO
    on Medi 18, 2020 at 8:25 am

    Mining company Eurasia Mining said it had appointed James Nieuwenhuys, formerly a non-executive director, as chief executive officer. Christian Schaffalitzky would remain as executive chairman. The directors agreed to release Dmitry Suschov from the board in order to allow him to focus as the company's chief M&A officer. Nieuwenhuys had held senior positions including CEO at South African Lesego Platinum Mining, Chief Operating Officer at Polyus Gold. At 9:25am: (LON:EUA) Eurasia Mining PLC share price was +0.75p at 19.75p Story provided by

What Investment Investment for retirement

Daily Express :: Finance Feed Simply The Best 7 Days A Week

Money | This is Money Your complete guide to personal finance and investing with news, predictions, advice, guides and opinion from the financial website of the year.

Daily Express :: City and Business Feed Simply The Best 7 Days A Week

Daily Express :: Personal Finance Feed Simply The Best 7 Days A Week

BBC News - Home BBC News - Home